Skip to content
Open access

Perfil de resistencia antimicrobiana de Burkholderia cepacia en el IGSS, Guatemala de 2015 a 2019

Jul 2026 · Revista Cientí­fica del Sistema de Estudios de Postgrado de la Universidad de San Carlos de Guatemala · Vol 9, pp. 123-133 · 0 citations · 5 references

TL;DR

The increase in antibiotic resistance observed for most of the antibiotics evaluated represents a relevant clinical challenge requiring continuous epidemiological surveillance and is a relevant clinical challenge requiring continuous epidemiological surveillance.

Abstract

Objective

to characterize the resistance profile of Burkholderia cepacia during the period 2015-2019, as well as to describe the demographic and clinical characteristics of the patients from whom the B. cepacia isolates were obtained.

Method

the study was retrospective, descriptive, cross-sectional. Statistical analysis was performed using the Kruskal-Wallis test and chi-square test.

Results

During the study period, 587 B. cepacia isolates were identified, with a higher percentage in males (61.8%), and the prevalence of B. cepacia infections was higher in adults (75%) compared to pediatric patients. Blood cultures yielded the highest number of B. cepacia isolates (64.3%), with an increase in resistant strains in the year-over-year distribution for most of the antibiotics evaluated.

Conclusion

the increase in antibiotic resistance observed for most of the antibiotics evaluated represents a relevant clinical challenge requiring continuous epidemiological surveillance. The majority of infected patients were adult males, and blood cultures yielded the highest number of B. cepacia isolates.

Read PDF

Similar papers

Open access 2026

Staphylococcus aureus resistente à meticilina (MRSA) em superfícies de interação infantil na Pediatria de um hospital universitário

BACKGROUND: This study evaluated environmental contamination by Staphylococcus aureus in the Pediatric Department of the Hospital de Clínicas of the Federal University of Uberlândia (HC-UFU), as well as the antimicrobial resistance profile of the isolated strains, aiming to understand the potential risks associated wit...

Edy Orlando, Samuell Luiz Silva, L. L. Melo et al. · 0 citations
Open access Aug 2026

Susceptibilidad antimicrobiana de enterobacterias adquiridas en comunidad que causan infecciones urinarias durante el embarazo

Escherichia coli was the predominant causative agent and exhibited low susceptibility to certain commonly used antibiotics at the primary care level, highlighting the need for local surveillance of antimicrobial resistance and optimization of empirical treatment.

J. Murillo-Llanes, F. Castro-Apodaca, Ignacio Osuna-Ramírez et al. · 0 citations
Open access Aug 2026

Prevalence and antibiotic resistance of Stenotrophomonas maltophilia in the Republic of Belarus in 2020–2024

Objective . To assess the prevalence and antibiotic resistance of S. maltophilia in Belarus over a five – year period (2020–2024). Materials and methods . A retrospective analysis of microbiological surveillance data (WHONET) was performed on clinical S. maltophilia isolates obtained from patients in six regio...

O. Yanovich, E. Karpova, N. Levshina et al. · 0 citations
Open access Aug 2026

Infecciones por Acinetobacter baumannii resistente a carbapenémicos: descripción de cohorte de adultos mayores internados

Carbapenem-resistant Acinetobacter baumannii (ABA-RCB) infections represent a critical global threat due to their limited therapeutic options. This observational, analytical and retrospective study (2021-2024) evaluated the clinical, epidemiological profile and outcome of 57 patients with confirmed ABA-RCB infection in...

Micaela Sandoval, P. González, Juan Ignacio Rodriguez Lia et al. · 0 citations
Open access Jul 2026

Molecular epidemiology and pharmacokinetic-pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain.

PURPOSE To analyse the epidemiology, antimicrobial susceptibility and molecular diversity of Neisseria gonorrhoeae isolates recovered in 2016-2017 at a tertiary hospital in northern Spain, and to perform a seven-year pharmacokinetic/pharmacodynamic (PK/PD) evaluation using susceptibility data from previous studies cond...

María Del Rosario Almela-Ferrer, María Carmen Nieto-Toboso, Elisabeth Montoya-Azpeitia et al. · 0 citations
Open access Jul 2026

Relebactam enhances the activity of imipenem against Burkholderia cepacia complex isolates.

BACKGROUND Burkholderia cepacia complex (BCC) is a group of ≥21 related organisms, including B. cepacia, Burkholderia cenocepacia, and Burkholderia multivorans. BCC can cause opportunistic infections in people who are immunocompromised and those with comorbidities or lung conditions. BCC exhibits intrinsic and acquired...

Lianzhu Liang, Joel Mane, David W. Hilbert et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.